Risk of neutropenia among clozapine users and non-users: results from 5,847 patients
Objective: Clozapine is underprescribed due to neutropenia risk. Blood tests every 3 months in those on continuous treatment for > 1 year who have never had an absolute neutrophil count (ANC) < 2,000/µL has been proposed as a monitoring strategy; however, there are no South American data to su...
Main Authors: | André Akira Sueno Goldani, Francisco Diego Rabelo-da-Ponte, Jacson Gabriel Feiten, Maria Ines R. Lobato, Paulo S. Belmonte-de-Abreu, Clarissa S. Gama |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Psiquiatria (ABP)
2021-10-01
|
Series: | Brazilian Journal of Psychiatry |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021005027202&tlng=en |
Similar Items
-
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01) -
CLOZAPINE RECHALLENGE WITH LITHIUM AFTER DOUBLE INDUCED NEUTROPENIA: A CASE REPORT
by: A. Kourti, et al.
Published: (2019-01-01) -
Neutropenia in patients treated with clozapine during COVID-19 infection
by: J. Marti Bonany, et al.
Published: (2021-04-01) -
Neutropenia in patients under treatment with clozapine and COVID-19 infection
by: S. Bonaccorso, et al.
Published: (2021-04-01) -
Clozapine‐associated severe eosinophilia following lithium rebound neutropenia: A case report
by: Kota Kikuchi, et al.
Published: (2020-12-01)